Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "Medical Aesthetics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.
The Medical Aesthetics Market was valued at USD 21.03 billion in 2023, and is expected to reach USD 39.87 billion by 2029, rising at a CAGR of 11.25%.
The global medical aesthetics market report contains exclusive data on 48 vendors. The market is highly competitive and dynamic, with numerous global, regional, and local vendors. These vendors offer end-users diverse medical aesthetic procedure products, treatments, and devices. The competition is intensified by prominent international players such as AbbVie, Bausch Health Companies, Candela, Cutera, Cynosure, El.En. S.p.A., Galderma, Johnson & Johnson, Lumenis, Merz Pharma, Sientra, Sinclair, and Sisram Medical.
Consistently influences market dynamics with its innovative solutions and advanced technologies. Leading market players continually introduce new aesthetic solutions with superior quality and technological features, contributing to the market's competitiveness. These companies also employ strategic business moves such as collaborations, mergers, and acquisitions of smaller and medium-sized market players.
The APAC region is projected to witness the highest CAGR in the global medical aesthetics market during the projection period. The growth is primarily driven by its substantial patient population and the rising number of elderly individuals seeking cosmetic enhancements. The favorable demographic trends and the increasing prevalence of conditions that can be addressed through aesthetic treatments propel market growth. Enhanced access to medical aesthetic care and the ongoing expansion of such services across the region further fuel this upward trajectory.
The increasing expenditure on cosmetic procedures and the swift acceptance of these treatments. This growth is particularly pronounced among the higher and middle-income patient segments, who are increasingly adopting aesthetic procedures as part of their lifestyle changes. The market's dynamic nature is evident in the varying access levels to aesthetic treatments across different APAC countries. In emerging markets such as India and South Korea, the affordability of medical aesthetic procedures drives high treatment rates.
MARKET TRENDS & DRIVERS
Increasing Demand for Neurotoxins
Adopting neurotoxins, particularly Botulinum toxin (known as Botox), has seen a significant rise globally, transforming the landscape of medical aesthetics. This surge is driven by the increasing demand for non-surgical, minimally invasive cosmetic procedures that offer effective and quick results with minimal downtime. Neurotoxins are primarily used to reduce the appearance of fine lines and wrinkles by temporarily paralyzing the underlying muscles, leading to smoother and more youthful-looking skin. The popularity of these treatments has expanded beyond traditional cosmetic applications to include therapeutic uses, further broadening their appeal and market growth.
One of the major factors contributing to the rise in neurotoxin adoption is the growing awareness and acceptance of aesthetic procedures. Social media platforms, celebrity endorsements, and the proliferation of beauty influencers have played a crucial role in normalizing cosmetic enhancements. This has increased consumer interest and willingness to undergo such treatments, particularly among younger demographics seeking preventive measures against aging. The accessibility and affordability of neurotoxin treatments have also improved, making them more attainable for a broader audience. The therapeutic applications of neurotoxins have also contributed to their widespread adoption.
Growing Advancements in Medical Aesthetic Procedures
Advancements in medical aesthetic procedures have revolutionized the field, offering enhanced effectiveness, safety, and patient satisfaction. The industry has seen significant innovation in surgical and non-surgical treatments, driven by technological developments, increased research, and evolving patient expectations. These advancements have broadened the scope of aesthetic procedures, making them more accessible and appealing to a wider range of individuals.
One of the most notable advancements is in the realm of non-surgical treatments. Minimally invasive procedures, such as injectable neurotoxins (like Botox) and dermal fillers, have become incredibly popular due to their ability to provide quick, noticeable results with minimal downtime. The formulations of these injectables have improved significantly, offering longer-lasting effects and more natural-looking outcomes. Additionally, advanced techniques in administering these treatments have enhanced precision and safety, reducing the risk of side effects and complications. Laser and light-based therapies have also seen tremendous advancements. Fractional lasers, intense pulsed light (IPL), and radiofrequency devices have become standard in treating various skin conditions, including pigmentation, scars, and wrinkles.
Increasing Consumer Base for aesthetics
The increasing consumer base for aesthetics is a testament to the growing demand for cosmetic procedures and treatments across diverse demographics. This expansion is driven by several factors, including societal acceptance, technological advancements, improved accessibility, and shifting cultural perceptions about beauty and self-care. One of the significant factors contributing to the increasing consumer base is the broadening societal acceptance of aesthetic procedures.
Once considered a luxury for the wealthy or a taboo subject, cosmetic enhancements have become mainstream. Influencers, celebrities, and social media platforms have played a crucial role in normalizing these procedures, openly discussing their experiences and sharing results. This visibility has reduced the stigma associated with aesthetic treatments, encouraging more people to consider and undergo such procedures. Technological advancements in medical aesthetics have also significantly contributed to the growing consumer base. Innovations in non-invasive and minimally invasive procedures, such as laser treatments, injectables, and body contouring technologies, offer effective results with minimal downtime and reduced risk compared to traditional surgical methods.
INDUSTRY RESTRAINTS
Side Effects Associated With Medical Aesthetic Treatment
After-procedure complications and customer complaints are significant considerations in aesthetic treatments despite technological advancements and practices aimed at reducing risks. Complications can range from minor issues such as swelling, bruising, or temporary discomfort to more serious complications like infection, scarring, or adverse treatment reactions.
While aesthetic treatments can enhance one's appearance and confidence, they are not without risks. Practitioners and patients alike must approach these procedures with caution, transparency, and a commitment to safety to minimize complications and address any customer complaints effectively. This ongoing diligence and responsiveness are essential for maintaining trust and credibility in aesthetic medicine. To minimize complications and customer complaints, practitioners must undergo comprehensive training and stay updated on the latest techniques and safety protocols.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value (USD) in 2023 | $21.03 Billion |
| Forecasted Market Value (USD) by 2029 | $39.87 Billion |
| Compound Annual Growth Rate | 11.2% |
| Regions Covered | Global |
Key Vendors
- AbbVie
- Bausch Health Companies
- Candela
- Cutera
- Cynosure
- El.En. S.p.A.
- Galderma
- Johnson & Johnson
- Lumenis
- Merz Pharma
- Sientra
- Sinclair
- Sisram medical
Other Prominent Vendors
- Aerolase
- Aesthetics Biomedical
- Asclepion Laser Technologies
- Astanza
- Beijing Sanhe Beauty S & T Co
- Beijing ADSS Development
- Biolitec
- Biotec Italia
- BISON Medical
- Bluecore
- Brera Medical Technologies
- BTL Aesthetics
- Cartessa
- Dominion Aesthetic Technologies
- Erchonia
- ENDYMED
- F Care Systems
- Gigaalaser
- GSD
- InMode Aesthetic Solutions
- Leaflife Technology
- LINLINE Medical Systems
- Lutronic
- Lynton Lasers
- MedArt ApS
- Microaire Surgical Instruments
- Medytox
- Meyer-Haake
- PhotoMedex
- Revance Aesthetics
- Sciton
- ThermiGen
- Venus Concept
- Wavemed
- Zimmer MedizinSysteme
SEGMENT INSIGHTS
By Product
- Injectables
- Energy-based Devices
- Cosmetic Implants
- Cosmeceuticals/Skin Care
By Procedure
- Non-Invasive
- Minimally Invasive
By Gender
- Women
- Men
By Application
- Skin Rejuvenation
- Body Contouring & Skin Tightening
- Breast Augmentation
- Hair Removal
- Others
By End-User
- Hospitals & Skin Clinics
- Medical Spas & Beauty Centers
- Homecare
By Age Group
- Between 34-50 Years
- Above 50 Years
- Below 34 Years
For more information about this report visit https://www.researchandmarkets.com/r/ur9706
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
